The Food and Drug Administration (FDA or Agency) is denying a request for a hearing submitted by Yong Sheng Jiao, also known as Yongsheng Jiao and Wilson Jiao (Jiao), and is issuing an order under the ...
The Food and Drug Administration has classified a recall of eggs sold at Costco caused by potential salmonella contamination as the highest risk level for infection. The FDA defines a Class I ...
To treat seizures, the typical starting dosage is 50 mg per day. Topamax is a brand-name drug approved by the Food and Drug Administration (FDA) to help prevent migraine headaches in adults and ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight ...
Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ... 30-40% of requests have been approved. Dostarlimab has been ...
With an FDA approval for Tryngolza (olezarsen) to treat the rare genetic disorder familial chylomicronemia syndrome (FCS), Ionis Pharmaceuticals enters a new era. While Ionis has gained several ...
NEW YORK, December 20, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI ® (encorafenib) in combination with ...
“It’s critical for the future of our country that food be a vehicle for wellness. Improving access to nutrition information is an important public health effort the FDA can undertake to help ...
Ionis Pharmaceuticals on Thursday won Food and Drug Administration approval of a therapy for patients with a rare and deadly genetic disease that impedes the body’s ability to break down fats ...
Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs and biologics, an expedited program designed to ...